2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.

Article Details

Citation

Kher S, Lake K, Sircar I, Pannala M, Bakir F, Zapf J, Xu K, Zhang SH, Liu J, Morera L, Sakurai N, Jack R, Cheng JF

2-Aryl-N-acyl indole derivatives as liver X receptor (LXR) agonists.

Bioorg Med Chem Lett. 2007 Aug 15;17(16):4442-6. Epub 2007 Jun 10.

PubMed ID
17587573 [ View in PubMed
]
Abstract

Structure-activity relationship studies on a series of Boc-indole derivatives as LXR agonists are described. Compound 1 was identified as an LXR agonist through structure-based virtual screening followed by high-throughput gene profiling. Replacement of the indan linker portion in 1 with an open-chain linker resulted in compounds with similar or improved in vitro potency and cellular functional activity. The Boc group at the N-1 position of the indole moiety can be replaced with a benzoyl group. The SAR studies led to the identification of compound 8, a potent LXRbeta agonist with an EC50 of 12 nM in the cofactor recruitment assay.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
TO-901317Oxysterols receptor LXR-alphaEC 50 (nM)407.522Details